Showing 4 of 4 recruiting trials for “Epithelioid sarcoma”
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
👨⚕️ Robert Maki, MD, MPH, Memorial Sloan Kettering Cancer Center📍 6 sites📅 Started Dec 2025View details ↗
Evaluate the Safety and Clinical Activity of HH2853
RecruitingNCT04300257 ↗
Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
RecruitingNCT03099681 ↗
An Observational Study on Epithelioid Sarcoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →